DocSym
β
Searchsearch
Search
(C91.3) Prolymphocytic leukaemia of b-cell type
More details coming soon
3 154 888 in individuals diagnosis prolymphocytic leukaemia of b-cell type confirmed
327 047 deaths with diagnosis prolymphocytic leukaemia of b-cell type
10% mortality rate associated with the disease prolymphocytic leukaemia of b-cell type
Diagnosis prolymphocytic leukaemia of b-cell type is diagnosed Men are 26.01% more likely than Women
1 987 810
Men receive the diagnosis prolymphocytic leukaemia of b-cell type
191 842 (9.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 167 078
Women receive the diagnosis prolymphocytic leukaemia of b-cell type
135 205 (11.6 %)Died from this diagnosis.
Risk Group for the Disease prolymphocytic leukaemia of b-cell type - Men aged 60-64 and Women aged 65-69
In Men diagnosis is most often set at age 0-95+
in in men, the disease manifests at any agein in women, the disease manifests at any age
In Women diagnosis is most often set at age 0-95+
Disease Features prolymphocytic leukaemia of b-cell type
Absence or low individual and public risk
Prolymphocytic leukaemia of b-cell type - what does this mean
Prolymphocytic leukaemia of b-cell type is a rare type of chronic lymphocytic leukaemia (cll) that is caused by an overproduction of b-cell lymphocytes in the bone marrow and peripheral blood. it is an aggressive form of cll that is characterised by the accumulation of abnormal b-cells in the blood and bone marrow, leading to a decrease in the production of normal red blood cells, white blood cells and platelets.
What happens during the disease - prolymphocytic leukaemia of b-cell type
Prolymphocytic leukaemia of b-cell type is a rare type of b-cell leukaemia caused by a mutation of the b-cell receptor, which leads to the uncontrolled growth and proliferation of b-cells in the bone marrow and peripheral blood. this mutation results in the production of abnormal, prolymphocytic b-cells that are unable to mature and differentiate, leading to an accumulation of immature b-cells in the bone marrow and peripheral blood. this overabundance of b-cells can cause symptoms such as fatigue, weight loss, and anemia.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
16 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Prolymphocytic leukaemia of b-cell type - Prevention
Prolymphocytic leukaemia of b-cell type can be prevented by avoiding exposure to environmental and occupational hazards such as radiation, chemicals, and solvents, as well as by following a healthy lifestyle that includes a balanced diet and regular exercise. vaccines may also be available for certain types of b-cell leukaemia.